4-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine hydrochloride, 95%, 1g

(R)-5-(tert-Butoxy)-5-oxo-4-(4,7,10-tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)pentanoic acid, 97%, 100mg

Methyl 2-(3-bromopyridin-4-yl)acetate, 97%, 1g

6-Methoxyisatin>97.0%(HPLC)(T)5g

Cyclotricatechylene, 98+%, 100mg

2',3'-dimethyl-3-(4-methoxyphenyl)propiophenone, 97.0%, 1g

2-methyl-1H,5H-pyrazolo[1,5-a]pyrimidin-5-one, 98%, 10g

5-Bromo-2-methylbenzamide, 95+%, 5g

2,5-Bis(trifluoromethyl)aniline, 97.0%, 25g

TERT-BUTYL 4,4-DIMETHYL-2,2-DIOXOOXATHIAZOLIDINE-3-CARBOXYLATE, 95.0%, 25g

Potassium (Bromomethyl)trifluoroborate>98.0%(T)1g

Methyl [4,5-dimethoxy-2-(4-trifluoromethyl-phenylsulfamoyl)-phenyl]-acetate, 99.0%, 1g

1-(4-Methoxyphenyl)butan-2-one, 97.0%, 1g